Walleye Trading’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $300K | Buy |
55,000
+10,200
| +23% | +$57.2K | ﹤0.01% | 2882 |
|
|
2025
Q4 | $314K | Sell |
44,800
-101,800
| -69% | -$797K | ﹤0.01% | 3123 |
|
|
2025
Q3 | $1.13M | Buy |
146,600
+38,200
| +35% | +$298K | ﹤0.01% | 2186 |
|
|
2025
Q2 | $944K | Sell |
108,400
-46,700
| -30% | -$338K | ﹤0.01% | 2240 |
|
|
2025
Q1 | $1.23M | Sell |
155,100
-20,800
| -12% | -$210K | ﹤0.01% | 1934 |
|
|
2024
Q4 | $1.6M | Sell |
175,900
-1,100
| -0.6% | -$10.6K | ﹤0.01% | 1834 |
|
|
2024
Q3 | $1.62M | Buy |
177,000
+28,800
| +19% | +$238K | ﹤0.01% | 1808 |
|
|
2024
Q2 | $1.45M | Buy |
148,200
+11,700
| +9% | +$143K | ﹤0.01% | 1810 |
|
|
2024
Q1 | $2.06M | Sell |
136,500
-384,200
| -74% | -$6.97M | ﹤0.01% | 1706 |
|
|
2023
Q4 | $11.2M | Buy |
520,700
+117,900
| +29% | +$2.18M | 0.02% | 719 |
|
|
2023
Q3 | $7.49M | Buy |
402,800
+12,000
| +3% | +$280K | 0.02% | 840 |
|
|
2023
Q2 | $9.9M | Sell |
390,800
-132,500
| -25% | -$3.33M | 0.03% | 590 |
|
|
2023
Q1 | $13.6M | Sell |
523,300
-8,300
| -2% | -$222K | 0.03% | 510 |
|
|
2022
Q4 | $12.6M | Buy |
531,600
+33,800
| +7% | +$911K | 0.04% | 539 |
|
|
2022
Q3 | $12.6M | Buy |
497,800
+125,100
| +34% | +$4.39M | 0.04% | 510 |
|
|
2022
Q2 | $12.4M | Buy |
372,700
+33,600
| +10% | +$1.43M | 0.04% | 511 |
|
|
2022
Q1 | $24.5M | Buy |
339,100
+50,400
| +17% | +$3.63M | 0.08% | 278 |
|
|
2021
Q4 | $26.5M | Buy |
288,700
+92,000
| +47% | +$11M | 0.09% | 226 |
|
|
2021
Q3 | $24.9M | Buy |
196,700
+88,700
| +82% | +$12.9M | 0.09% | 218 |
|
|
2021
Q2 | $18M | Buy |
108,000
+92,300
| +588% | +$15M | 0.07% | 262 |
|
|
2021
Q1 | $2.85M | Sell |
15,700
-39,553
| -72% | -$9.17M | 0.01% | 1057 |
|
|
2020
Q4 | $11M | Buy |
55,253
+4,953
| +10% | +$1.01M | 0.05% | 357 |
|
|
2020
Q3 | $11M | Buy |
50,300
+6,500
| +15% | +$1.38M | 0.06% | 249 |
|
|
2020
Q2 | $8.36M | Sell |
43,800
-800
| -2% | -$140K | 0.05% | 333 |
|
|
2020
Q1 | $6.91M | Sell |
44,600
-5,500
| -11% | -$640K | 0.05% | 284 |
|
|
2019
Q4 | $4.19M | Sell |
50,100
-20,400
| -29% | -$1.55M | 0.03% | 675 |
|
|
2019
Q3 | $4.77M | Buy |
70,500
+30,400
| +76% | +$2M | 0.04% | 488 |
|
|
2019
Q2 | $2.66M | Buy |
40,100
+12,100
| +43% | +$705K | 0.02% | 836 |
|
|
2019
Q1 | $1.56M | Buy |
28,000
+12,700
| +83% | +$775K | 0.01% | 1281 |
|
|
2018
Q4 | $758K | Buy |
15,300
+11,900
| +350% | +$728K | 0.01% | 2026 |
|
|
2018
Q3 | $294K | Buy |
+3,400
| New | +$242K | ﹤0.01% | 3418 |
|
Other funds holding TDOC
VPM
VCM
VC
Walleye Trading's TDOC Position: Q1 2026 in Review
Walleye Trading increased its Teladoc Health (TDOC) stake by 18% in Q1 2026, buying an estimated $199K and bringing the position to 233,646 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1994.
Walleye Trading first reported a position in TDOC in Q3 2016 and has held it in 21 quarters since. The position peaked at $75.7M in Q4 2021. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.
- Walleye Trading held 233,646 shares of Teladoc Health worth $1.27M as of Q1 2026.
- Walleye Trading bought 35,413 Teladoc Health shares in Q1 2026, an estimated $199K.
- Teladoc Health made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #1994 holding.
- Walleye Trading first reported a position in Teladoc Health in Q3 2016 and has held it in 21 quarters since.
- Walleye Trading's Teladoc Health position peaked at $75.7M in Q4 2021.
- 322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.
Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.